Tracheobronchial (airway) stents are those devices utilized to splint narrowed airways open. The narrow or stenotic, airways result from abnormal granulation tissue, metastatic cancers, lung cancer, tuberculosis, infections, ...
The global non vascular stent market was valued at $1.6 billion in 2023, and is projected to reach $2.7 billion by 2035, growing at a CAGR of 4.5% from 2024 to 2035.
